Working with experts at Vanderbilt University, Hallarn's team interviewed groups of autistic children, autism advocates and researchers to come up with five additional questions which have been added to the registration procedure for people who have identified themselves with ASD during sign up. The relevant questions help identify behaviors and medications that will make children eligible for certain studies. The registry allows for a range of participation levels from volunteers – some research involve likely to a laboratory or taking medication, other studies are searching for volunteers to take on-line health information surveys only. ‘Research studies can be stalled or prematurely closed if they’re struggling to enroll enough study participants. We're hopeful that the simplicity of the registry shall encourage visitors to join,’ said Hallarn.Under one such contract in negotiations in Asia presently, ADI has the potential of getting approximately US$80 per individual tested. In another set up negotiated in america marketplace for pan tumor screening already, ADI anticipates receiving around US$150 per individual tested. Lastly, by late 2010 ADI anticipates the launch of its following generation Onko-Sure IVD cancer tumor test kit, which is likely to deliver increased specificity and sensitivity; greater test kit price points therefore. Core Item Message: ADI’s general primary marketing message for Onko-Sure IVD is as follows: Onko-Sure is an EASY Cancer Evaluation Test.